Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL

被引：0
|
作者：
Jung Jin Hwang
Yong Sook Kim
Taelim Kim
Mi Joung Kim
In Gab Jeong
Je-Hwan Lee
Jene Choi
Sejin Jang
Seonggu Ro
Choung-Soo Kim
机构：
[1] University of Ulsan College of Medicine,Department of Convergence Medicine
[2] Asan Medical Center,Institute for Innovative Cancer Research
[3] University of Ulsan College of Medicine,Department of Urology
[4] Asan Medical Center,Department of Internal Medicine & Laboratory Medicine
[5] University of Ulsan College of Medicine,Department of Pathology
[6] Asan Medical Center,undefined
[7] University of Ulsan College of Medicine,undefined
[8] Asan Medical Center,undefined
[9] University of Ulsan College of Medicine,undefined
[10] Asan Medical Center,undefined
[11] PiMedBio,undefined
[12] Inc.,undefined
来源：
Investigational New Drugs | 2019年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 (https://doi.org/10.1016/j.juro.2010.07.035).
引用
收藏
页码：796 / 796
相关论文
共 32 条
  • [1] A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
    Jung Jin Hwang
    Yong Sook Kim
    Taelim Kim
    Mi Joung Kim
    In Gab Jeong
    Je-Hwan Lee
    Jene Choi
    Sejin Jang
    Seonggu Ro
    Choung-Soo Kim
    Investigational New Drugs, 2012, 30 : 1434 - 1442
  • [2] A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
    Hwang, Jung Jin
    Kim, Yong Sook
    Kim, Taelim
    Kim, Mi Joung
    Jeong, In Gab
    Lee, Je-Hwan
    Choi, Jene
    Jang, Sejin
    Ro, Seonggu
    Kim, Choung-Soo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1434 - 1442
  • [3] A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL (vol 30, pg 1434, 2012)
    Hwang, Jung Jin
    Kim, Yong Sook
    Kim, Taelim
    Kim, Mi Joung
    Jeong, In Gab
    Lee, Je-Hwan
    Choi, Jene
    Jang, Sejin
    Ro, Seonggu
    Kim, Choung-Soo
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 796 - 796
  • [4] Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells
    Kim, Hak-Ryul
    Jung, Jae-Wan
    Hwang, Ki-Eun
    Park, Chul
    Jeong, Eun-Taik
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [5] Histone deacetylase inhibitor; CG005, is a novel anticancer drug; as a combination drug with docetaxel in prostate cancer
    Kim, Yong Sook
    Kim, Mi Joung
    Choi, Jene
    Jang, Sejin
    Lee, Je-hwan
    Ro, Seonggu
    Kim, Choung-soo
    Hwang, Jung Jin
    CANCER RESEARCH, 2011, 71
  • [6] Histone Deacetylase Inhibitor Potentiates Anticancer Effect of Docetaxel via Modulation of Bcl-2 Family Proteins and Tubulin in Hormone Refractory Prostate Cancer Cells
    Hwang, Jung Jin
    Kim, Yong Sook
    Kim, Mi Joung
    Kim, Dong Eun
    Jeong, In Gab
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2557 - 2564
  • [7] Colorectal cancer cell lines with high BCL-XL and low MCL-1 expression are sensitive to a potent and selective BCL-XL inhibitor
    Lam, Lloyd T.
    Zhang, Haichao
    Xue, John
    Hessler, Paul
    Tahir, Stephen K.
    Chen, Jun
    Jin, Sha
    Souers, Andrew J.
    Leverson, Joel D.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Anti-leukemic activity of a novel histone deacetylase inhibitor, CG200745, via induction of mitochondrial dysfunction in acute myeloid leukemia
    Hur, Eun-hye
    Goo, Bon-Kwan
    Kim, Sung-Doo
    Kim, Minhee
    Choi, Yunsuk
    Lee, Kyoo-Hyung
    Lee, Jung-Hee
    Kim, Dae-Young
    Hwang, Jung Jin
    Kim, Choung-Soo
    Ro, Seonggu
    Lee, Je-Hwan
    CANCER RESEARCH, 2012, 72
  • [9] Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
    Eun-Taex Oh
    Moon-Taek Park
    Bo-Hwa Choi
    Seonggu Ro
    Eun-Kyung Choi
    Seong-Yun Jeong
    Heon Joo Park
    Investigational New Drugs, 2012, 30 : 435 - 442
  • [10] Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
    Oh, Eun-Taex
    Park, Moon-Taek
    Choi, Bo-Hwa
    Ro, Seonggu
    Choi, Eun-Kyung
    Jeong, Seong-Yun
    Park, Heon Joo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 435 - 442
1234